Trauma Monthly

Published by: Kowsar

The Advantages and Disadvantages of Methods Used to Control Liver Bleeding: A Review

Saeed Nouri 1 , Mohammad Reza Sharif 2 , * , Hasan Afzali 2 , Alireza Sharif 2 and Mojtaba Satkin 3
Authors Information
1 Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Trauma Research Center, Kashan University of Medical Sciences, Kashan, IR Iran
3 Behavioral Sciences Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Trauma Monthly: November 1, 2015, 20 (4); e28088
  • Published Online: November 23, 2015
  • Article Type: Review Article
  • Received: February 19, 2015
  • Revised: August 15, 2015
  • Accepted: August 17, 2015
  • DOI: 10.5812/traumamon.28088

To Cite: Nouri S, Sharif M R, Afzali H, Sharif A, Satkin M. The Advantages and Disadvantages of Methods Used to Control Liver Bleeding: A Review, Trauma Mon. 2015 ; 20(4):e28088. doi: 10.5812/traumamon.28088.

Abstract
Copyright © 2015, Trauma Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnote
References
  • 1. Hendriks HG, van der Meer J, de Wolf JT, Peeters PM, Porte RJ, de Jong K, et al. Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation. Transpl Int. 2005; 17(11): 673-9[DOI][PubMed]
  • 2. Stainsby D, Williamson L, Jones H, Cohen H. 6 Years of shot reporting--its influence on UK blood safety. Transfus Apher Sci. 2004; 31(2): 123-31[DOI][PubMed]
  • 3. de Boer MT, Molenaar IQ, Hendriks HG, Slooff MJ, Porte RJ. Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Dig Surg. 2005; 22(4): 265-75[DOI][PubMed]
  • 4. Porte RJ, Hendriks HG, Slooff MJ. Blood conservation in liver transplantation: The role of aprotinin. J Cardiothorac Vasc Anesth. 2004; 18(4 Suppl): 31s-7s[PubMed]
  • 5. Ramos E, Dalmau A, Sabate A, Lama C, Llado L, Figueras J, et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl. 2003; 9(12): 1320-7[DOI][PubMed]
  • 6. Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 1995; 38(2): 185-93[PubMed]
  • 7. Champion HR, Bellamy RF, Roberts CP, Leppaniemi A. A profile of combat injury. J Trauma. 2003; 54(5 Suppl)-9[DOI][PubMed]
  • 8. Nouri S, Sharif MR. Investigating the Effect of Zinc Chloride on Liver Hemorrhage Control; an Animal Model Study. J Isfahan Med Sch. 2015; 32(308): 1845-54
  • 9. McBee WL, Koerner KR. Review of hemostatic agents used in dentistry. Dent Today. 2005; 24(3): 62-5[PubMed]
  • 10. Lemon RR, Steele PJ, Jeansonne BG. Ferric sulfate hemostasis: effect on osseous wound healing. Left in situ for maximum exposure. J Endod. 1993; 19(4): 170-3[PubMed]
  • 11. Odabas ME, Erturk M, Cinar C, Tuzuner T, Tulunoglu O. Cytotoxicity of a new hemostatic agent on human pulp fibroblasts in vitro. Med Oral Patol Oral Cir Bucal. 2011; 16(4)-7[PubMed]
  • 12. Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, et al. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res. 2008; 36(1): 163-70[PubMed]
  • 13. Meric Teker A, Korkut AY, Kahya V, Gedikli O. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis. Eur Arch Otorhinolaryngol. 2010; 267(9): 1377-81[DOI][PubMed]
  • 14. Cinar C, Odabas ME, Akca G, Isik B. Antibacterial effect of a new haemostatic agent on oral microorganisms. J Clin Exp Dent. 2012; 4(3)-5[DOI][PubMed]
  • 15. Schriver DA, White CB, Sandor A, Rosenthale ME. A profile of the rat gastrointestinal toxicity of drugs used to treat inflammatory diseases. Toxicol Appl Pharmacol. 1975; 32(1): 73-83[PubMed]
  • 16. Nouri S, Sharif MR, Hosseinpour M, Ehteram H. The hemostatic effect of aluminum sulfate in liver bleeding in rat. FEYZ. 2015; 18(6): 524-30
  • 17. Marietta M, Facchini L, Pedrazzi P, Busani S, Torelli G. Pathophysiology of bleeding in surgery. Transplant Proc. 2006; 38(3): 812-4[DOI][PubMed]
  • 18. Porte RJ, Knot EA, Bontempo FA. Hemostasis in liver transplantation. Gastroenterology. 1989; 97(2): 488-501[PubMed]
  • 19. Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007; 24(4): 250-8[DOI][PubMed]
  • 20. Cogbill TH, Moore EE, Jurkovich GJ, Feliciano DV, Morris JA, Mucha P. Severe hepatic trauma: a multi-center experience with 1,335 liver injuries. J Trauma. 1988; 28(10): 1433-8[PubMed]
  • 21. Beal SL. Fatal hepatic hemorrhage: an unresolved problem in the management of complex liver injuries. J Trauma. 1990; 30(2): 163-9[PubMed]
  • 22. Kang Y, Audu P. Coagulation and liver transplantation. Int Anesthesiol Clin. 2006; 44(4): 17-36[DOI][PubMed]
  • 23. Poliachik SL, Chandler WL, Mourad PD, Ollos RJ, Crum LA. Activation, aggregation and adhesion of platelets exposed to high-intensity focused ultrasound. Ultrasound Med Biol. 2001; 27(11): 1567-76[PubMed]
  • 24. Nouri S, Sharif MR. Use of ferric sulfate to control hepatic bleeding. Trauma Mon. 2015; 20(1)[DOI][PubMed]
  • 25. van der Bilt JD, Livestro DP, Borren A, van Hillegersberg R, Borel Rinkes IH. European survey on the application of vascular clamping in liver surgery. Dig Surg. 2007; 24(6): 423-35[DOI][PubMed]
  • 26. Bourgain RH, Six F. A continuous registration method in experimental arterial thrombosis in the rat. Thromb Res. 1974; 4(4): 599-607[PubMed]
  • 27. Nakajima Y, Shimamura T, Kamiyama T, Matsushita M, Sato N, Todo S. Control of intraoperative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals. Surg Today. 2002; 32(1): 48-52[PubMed]
  • 28. Hladovec J. The effect of some platelet aggregating and potential thrombosis-promoting substances on the development of experimental arterial thrombosis. Thromb Diath Haemorrh. 1973; 29(1): 196-200[PubMed]
  • 29. Lesurtel M, Selzner M, Petrowsky H, McCormack L, Clavien PA. How should transection of the liver be performed?: a prospective randomized study in 100 consecutive patients: comparing four different transection strategies. Ann Surg. 2005; 242(6): 814-22[PubMed]
  • 30. Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y, et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg. 1998; 187(6): 620-5[PubMed]
  • 31. Smyrniotis V, Kostopanagiotou G, Theodoraki K, Tsantoulas D, Contis JC. The role of central venous pressure and type of vascular control in blood loss during major liver resections. Am J Surg. 2004; 187(3): 398-402[DOI][PubMed]
  • 32. Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg. 1998; 85(8): 1058-60[DOI][PubMed]
  • 33. Bismuth H, Castaing D, Garden OJ. Major hepatic resection under total vascular exclusion. Ann Surg. 1989; 210(1): 13-9[PubMed]
  • 34. Schroeder RA, Collins BH, Tuttle-Newhall E, Robertson K, Plotkin J, Johnson LB, et al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2004; 18(4): 438-41[PubMed]
  • 35. Massicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl. 2006; 12(1): 117-23[DOI][PubMed]
  • 36. Berrevoet F, de Hemptinne B. Use of topical hemostatic agents during liver resection. Dig Surg. 2007; 24(4): 288-93[DOI][PubMed]
  • 37. Heaton N. Advances and methods in liver surgery: haemostasis. Eur J Gastroenterol Hepatol. 2005; 17 Suppl 1-12[PubMed]
  • 38. Chapman WC, Clavien PA, Fung J, Khanna A, Bonham A. Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Arch Surg. 2000; 135(10): 1200-4[PubMed]
  • 39. Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg. 2004; 139(11): 1148-54[DOI][PubMed]
  • 40. Jackson MR. Fibrin sealants in surgical practice: An overview. Am J Surg. 2001; 182(2 Suppl): 1s-7s[PubMed]
  • 41. Palanker D, Vankov A, Freyvert Y, Huie P. Pulsed electrical stimulation for control of vasculature: temporary vasoconstriction and permanent thrombosis. Bioelectromagnetics. 2008; 29(2): 100-7[DOI][PubMed]
  • 42. Nouri S, Sharif MR, Tabatabaei F, Farokhi S. Investigating the effect of zinc chloride to control external bleeding in rats. Nurs Midwifery Stud. 2014; 3(3)[PubMed]
  • 43. Sharif MR, Nouri S, Jamali B, Khorshidi AM. Comparison the Effect of Zinc Chloride and Aluminum Chloride in Controlling Liver Bleeding: An Animal Model Study. Iran J Surg. 2014; (22): 9-17
  • 44. Silverstein ME, Chvapil M. Experimental and clinical experiences with collagen fleece as a hemostatic agent. J Trauma. 1981; 21(5): 388-93[PubMed]
  • 45. Nouri S, Khorshidi AH, Farokhi SH, Sharif MR. Comparing the Effect of Ferric Sulfate and Zinc Chloride in Controlling Liver Bleeding in an Animal Model Study. Sci J Hamadan Univ Med Sci. 2015; 21(4): 263-70
  • 46. Siemer S, Lahme S, Altziebler S, Machtens S, Strohmaier W, Wechsel HW, et al. Efficacy and safety of TachoSil as haemostatic treatment versus standard suturing in kidney tumour resection: a randomised prospective study. Eur Urol. 2007; 52(4): 1156-63[DOI][PubMed]
  • 47. Nouri S, Sharif MR, Sahba S. The effect of ferric chloride on superficial bleeding. Trauma Mon. 2015; 20(1)[DOI][PubMed]
  • 48. Takacs I, Wegmann J, Horvath S, Ferencz A, Ferencz S, Javor S, et al. Efficacy of different hemostatic devices for severe liver bleeding: a randomized controlled animal study. Surg Innov. 2010; 17(4): 346-52[DOI][PubMed]
  • 49. Groenland TH, Porte RJ. Antifibrinolytics in liver transplantation. Int Anesthesiol Clin. 2006; 44(3): 83-97[DOI][PubMed]
  • 50. Porte RJ, Leebeek FW. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs. 2002; 62(15): 2193-211[PubMed]
  • 51. Nouri S, Amirbeigy M, Hosseinpour M, Abdorrahim KE, Sharif MR, Amirbeigy MK. Evaluation of the Hemostatic Effect of Ferric Sulphate in Controlling External Bleeding in Mouse at Kashan University of Medical Sciences. Iran J Surg. 2012; 22(2): 1-8
  • 52. Ozier Y, Schlumberger S. Pharmacological approaches to reducing blood loss and transfusions in the surgical patient. Can J Anaesth. 2006; 53(6 Suppl)-9[PubMed]
  • 53. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2007; (4)[DOI][PubMed]
  • 54. Dalmau A, Sabate A, Acosta F, Garcia-Huete L, Koo M, Sansano T, et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg. 2000; 91(1): 29-34[PubMed]
  • 55. Molenaar IQ, Warnaar N, Groen H, Tenvergert EM, Slooff MJ, Porte RJ. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant. 2007; 7(1): 185-94[DOI][PubMed]
  • 56. Warnaar N, Mallett SV, de Boer MT, Rolando N, Burroughs AK, Nijsten MW, et al. The impact of aprotinin on renal function after liver transplantation: an analysis of 1,043 patients. Am J Transplant. 2007; 7(10): 2378-87[DOI][PubMed]
  • 57. Nouri S, Sharif MR, Khorshidi AH, Panahi Y. Comparison the Effect of Calcium Sulfate and Ferric Chloride in Controlling Liver Bleeding; An Animal Model Study. Zanjan Univ Med Sci. 2015; 23(96): 46-56
  • 58. Wu CC, Ho WM, Cheng SB, Yeh DC, Wen MC, Liu TJ, et al. Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy. Ann Surg. 2006; 243(2): 173-80[DOI][PubMed]
  • 59. Pereboom IT, de Boer MT, Porte RJ, Molenaar IQ. Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss. Dig Surg. 2007; 24(4): 282-7[DOI][PubMed]
  • 60. Lodge JP, Jonas S, Oussoultzoglou E, Malago M, Jayr C, Cherqui D, et al. Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial. Anesthesiology. 2005; 102(2): 269-75[PubMed]
  • 61. Planinsic RM, van der Meer J, Testa G, Grande L, Candela A, Porte RJ, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. Liver Transpl. 2005; 11(8): 895-900[DOI][PubMed]
  • 62. Lodge JP, Jonas S, Jones RM, Olausson M, Mir-Pallardo J, Soefelt S, et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005; 11(8): 973-9[DOI][PubMed]
  • 63. Hendriks HG, Meijer K, de Wolf JT, Klompmaker IJ, Porte RJ, de Kam PJ, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation. 2001; 71(3): 402-5[PubMed]
  • 64. Meijer K, Hendriks HG, De Wolf JT, Klompmaker IJ, Lisman T, Hagenaars AA, et al. Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis. Blood Coagul Fibrinolysis. 2003; 14(2): 169-74[DOI][PubMed]
  • 65. Vincent JL, Rossaint R, Riou B, Ozier Y, Zideman D, Spahn DR. Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding--a European perspective. Crit Care. 2006; 10(4)[DOI][PubMed]
  • 66. Levy JH, Fingerhut A, Brott T, Langbakke IH, Erhardtsen E, Porte RJ. Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile. Transfusion. 2006; 46(6): 919-33[DOI][PubMed]
  • 67. Nouri S, Sharif MR, Jamali B, Panahi Y. Effect of Ferric Sulfate and Ferric Chloride in Controlling Liver Bleeding; An Animal Model Study. J Physiol Pharmacol. 2015; 18(4): 429-36
  • 68. Lentschener C, Benhamou D, Mercier FJ, Boyer-Neumann C, Naveau S, Smadja C, et al. Aprotinin reduces blood loss in patients undergoing elective liver resection. Anesth Analg. 1997; 84(4): 875-81[PubMed]
  • 69. Nouri S, Sharif MR. Methods Used in Controlling Liver Hemorrhage; A Review Article. Iran J Surg. 2013; 22(3): 1-10
  • 70. Nouri S, Sharif MR, Panahi Y, Ghanei M, Jamali B. Efficacy and safety of aluminum chloride in controlling external hemorrhage: an animal model study. Iran Red Crescent Med J. 2015; 17(3)[DOI][PubMed]
  • 71. Czerny M, Verrel F, Weber H, Muller N, Kircheis L, Lang W, et al. Collagen patch coated with fibrin glue components. Treatment of suture hole bleedings in vascular reconstruction. J Cardiovasc Surg (Torino). 2000; 41(4): 553-7[PubMed]
  • 72. Nouri S, Sharif MR. Efficacy and safety of ferric chloride in controlling hepatic bleeding; an animal model study. Hepat Mon. 2014; 14(6)[DOI][PubMed]
  • 73. Nouri S, Farokhi SH, Jamali B, Sharif M. R. . Alum in Controlling Hepatic Bleeding; An Animal Model Study. Thrita. 2014; 3(3)
  • 74. Nouri S, Sharif M. Hemostatic Effect of Aluminum Chloride in Liver Bleeding: An Animal Model Study. Tehran Univ Med J. 2014; 72(7): 435-42
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments